Moreover, potential biomarkers like Syt1 and Idh3a could be considered to be applied in clinical practice for early identification of cold wave-related stroke among inpatients during cold waves, and prophylactic drugs like batroxobin for treatment of cold wave-related stroke [71, 79]. Here, IDH3A is linked to stroke disorder.